Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Intralesional Platelet Rich Plasma in Patients of De Quervain's Tenosynovitis

NCT06651034 is registered in ClinicalTrials.gov with Muhammad Aamir Latif as lead sponsor.

NCT NCT06651034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06651034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Intralesional Platelet Rich Plasma in Patients of De Quervain's Tenosynovitis
Lead sponsor
Muhammad Aamir Latif
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2021
Completion date
October 30, 2022
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

de quervain tenosynovitis